Compugen (CGEN) director discloses initial shares, RSUs and option grants

Rhea-AI Filing Summary

Compugen Ltd director Livnat Savitzky Kinneret filed an initial ownership report showing direct holdings of ordinary shares, restricted stock units (RSUs), and stock options. She holds 13,350 ordinary shares, including 9,216 RSUs. Of these RSUs, 1,716 vest in 11 equal quarterly installments commencing on April 1, 2026, and 7,500 vest 25% on October 1, 2026 with the remainder in 12 equal quarterly installments thereafter, all subject to continued service.

The filing also lists several option awards over ordinary shares with exercise prices ranging from $1.15 to $14.40 per share and expiration dates from August 6, 2028 through August 5, 2035. These options have various vesting schedules, including grants that are fully vested and others that vested or vest 25% on specific dates such as April 1, 2023, October 1, 2024, October 1, 2025, and October 1, 2026, with remaining portions in 12 equal quarterly installments, conditioned on her continued service to Compugen.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Livnat Savitzky Kinneret

(Last) (First) (Middle)

C/O COMPUGEN LTD.

26 HAROKMIM STREET

(Street)

HOLON 5885849

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ]

3a. Foreign Trading Symbol
[CGEN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	13,350(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	(2)	08/06/2028	Ordinary Shares	35,000	$3.85	D
Share Option (right to buy)	(2)	08/01/2029	Ordinary Shares	10,000	$3.24	D
Share Option (right to buy)	(2)	07/29/2030	Ordinary Shares	10,000	$14.4	D
Share Option (right to buy)	(2)	07/27/2031	Ordinary Shares	10,000	$6.45	D
Share Option (right to buy)	(3)	03/24/2032	Ordinary Shares	10,000	$3.24	D
Share Option (right to buy)	(4)	08/03/2033	Ordinary Shares	10,000	$1.15	D
Share Option (right to buy)	(5)	07/31/2034	Ordinary Shares	8,000	$1.69	D
Share Option (right to buy)	(5)	09/12/2034	Ordinary Shares	12,000	$1.97	D
Share Option (right to buy)	(6)	08/05/2035	Ordinary Shares	10,000	$1.46	D

Explanation of Responses:

1. Includes 9,216 restricted stock units ("RSUs"). 1,716 RSUs vest in 11 equal quarterly installments commencing on April 1, 2026; and 7,500 RSUs vest 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

2. Fully vested.

3. This option vested 25% on April 1, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

4. This option vested 25% on October 1, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

5. This option vested 25% on October 1, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

6. This option vests 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

	/s/ Kinneret Livnat Savitzky	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing for COMPUGEN LTD (CGEN) show for Livnat Savitzky Kinneret?

The Form 3 shows Livnat Savitzky Kinneret’s initial holdings in Compugen, including ordinary shares, restricted stock units, and multiple stock option grants. It details exercise prices, expiration dates, and vesting schedules tied to her continued service to the company.

How many ordinary shares and RSUs does Livnat Savitzky Kinneret hold in CGEN?

She holds 13,350 ordinary shares, including 9,216 restricted stock units. The RSUs vest over time, with 1,716 vesting in 11 quarterly installments from April 1, 2026, and 7,500 vesting 25% on October 1, 2026 and quarterly thereafter, subject to continued service.

What are the key vesting terms of Livnat Savitzky Kinneret’s RSUs in Compugen (CGEN)?

Her RSUs vest gradually. 1,716 RSUs vest in 11 equal quarterly installments starting April 1, 2026. Another 7,500 RSUs vest 25% on October 1, 2026, with the remaining 75% vesting in 12 equal quarterly installments, all contingent on her continued service to Compugen.

What stock options are reported for Livnat Savitzky Kinneret in the CGEN Form 3?

The filing lists several share options over Compugen ordinary shares with exercise prices between $1.15 and $14.40 and expiration dates from August 6, 2028 to August 5, 2035. These options have staggered vesting schedules, some fully vested and others vesting quarterly over time.

Are Livnat Savitzky Kinneret’s Compugen (CGEN) stock options already vested?

Some options are fully vested, while others vest over time. Certain grants vested or vest 25% on dates such as April 1, 2023, October 1, 2024, October 1, 2025, and October 1, 2026, with the remaining portions vesting in 12 equal quarterly installments, subject to continued service.

Does the CGEN Form 3 for Livnat Savitzky Kinneret show any recent share purchases or sales?

The Form 3 is an initial ownership report and lists holdings in ordinary shares, RSUs, and options. It does not identify any transactions as open-market purchases or sales; it focuses on her existing equity-based positions and their vesting and expiration terms.